In the follow-up, in vivo animal experiments are needed to further explore the role of NDR1 in regulating IL-17-induced infectious diseases or autoimmune diseases, so as to provide reference for using NDR1 as a new target for the treatment of this disease. Here, IL17A is linked to autoimmune disease.